Behaviors and willingness to support HPV vaccination for women: a cross-sectional study of young adult men in China Authors: Weiyi Wang Published: 2024 ABSTRACT AbstractBackgroundMen’s involvement in and support for women’s decision-making concerning human papillomavirus (HPV) vaccination is crucial. However, the support provided by men to promote HPV vaccination among women, as a crucial part of intimate relationships has received limited attention. This study examined the behaviors and willingness of young Chinese adult men to support HPV vaccination in women and explored potential factors influencing supportive behaviors and willingness.MethodsFrom December 2020 to January 2021, a cross-sectional study was conducted among 1014 young men from eight universities in Zhejiang Province, China. The survey questionnaire assessed behaviors and willingness to support HPV vaccination, HPV-related knowledge, information seeking for male HPV vaccination, attitudes toward women’s vaccination benefits, and sociodemographic variables. Multivariable logistic regression analyses adjusting for all covariates were used to identify factors associated with supportive behaviors and willingness.ResultsOnly 48.4% of respondents reported having acquired and shared information about HPV vaccination with loved ones, whereas 41.3% recommended HPV vaccination. Approximately 80% of the participants without supportive behaviors reported a willingness to support the vaccination. Positive attitudes toward the benefits of women’s HPV vaccination, active seeking of information on male HPV vaccination, and relevant sociodemographic and health-related variables were associated with vaccination-supportive behaviors or willingness.ConclusionsYoung men expressed a relatively low level of support for female HPV vaccination. Promoting active information seeking regarding HPV vaccination among men and emphasizing the benefits of HPV vaccination for women could potentially foster more supportive behaviors. Targeted health education should include men to promote their involvement in shared decision-making regarding female HPV vaccinations.Keywords: HPV vaccination, Men’s involvement, Women’s health, Young adults, Supportive behavior, Willingness, Social Support, China Background Cervical cancer is one of the most common malignancies affecting the reproductive system of women in China. It has the second highest incidence rate after breast cancer and a relatively high mortality rate [1, 2]. Persistent infection with high-risk human papillomavirus (HPV) is the primary cause of cervical cancer [3]. HPV is commonly transmitted through sexual contact, and women and men are at risk of infection within a certain period after engaging in sexual activity [4, 5]. Owing to their unique physiological structures, women are more susceptible to health issues caused by HPV infection than men [6]. It is estimated that over 80% of women will contract HPV at some point in their lives, with a higher likelihood of infection among young women of reproductive age [7]. Related research shows that the prevalence of high-risk HPV infection among Chinese women aged 25–45 years is 19.9% [8], while the 20–24 age group experiences a peak in HPV infection [9]. HPV vaccination is one of the most effective strategies for preventing cervical cancer and other HPV-related diseases [10]. However, optimal outcomes in cervical cancer prevention can only be achieved through the widespread acceptance and utilization of the HPV vaccine. Since the introduction of the HPV vaccine in 2006, countries have encountered obstacles and difficulties in enhancing HPV vaccination coverage [11–13]. China initiated the promotion of HPV vaccination in 2016, a decade later than in many other countries, and the coverage of HPV vaccination remains low. By 2022, the first-dose coverage for females aged 9–45 years was only 10.15%, and the third-dose coverage was only 6.21% [14]. Moreover, there is no current national HPV vaccination immunization program in China, and the development of relevant policies is still underway. This poses significant challenges and difficulties in promoting HPV vaccination in China. Social support is commonly recognized as a strong predictor of healthy behavior adoption [15, 16], which is rooted in intimate relationships between individuals [17]. Women are more inclined to pursue preventive health screenings and seek information when they receive social support [18]. Previous studies have consistently demonstrated the crucial role of support from parents, peers, and healthcare providers in promoting HPV vaccine uptake among adolescents and young adult women [19–21]. However, the support provided by men to promote HPV vaccination among women, as an integral part of intimate relationships, has received relatively little research attention. A few studies have shown that approval and endorsement from a spouse or partner significantly influence women’s HPV vaccination willingness and uptake [22, 23]. This highlights the profound impact of men on women’s HPV vaccination, necessitating further exploration into the potential role their support plays in women’s health. In many conservative Asian cultural contexts, the stigma attached to sexually transmitted diseases (STDs), including HPV infection, has rendered them a “taboo” topic for women to discuss openly, placing a considerable psychological burden on women [24]. A survey conducted among Chinese unmarried young women indicated that when infected with STDs, they were more inclined to confide in or seek support from close friends and healthcare professionals [25]. Unfortunately, the role of male partners often diminishes during this process. This is partly because sharing information about the disease often implies sharing responsibility, which can sometimes lead to stigmatizing responses from male partners, such as blame or disregard. As significant participants in intimate relationships, the understanding and support of men have important implications for women’s reproductive health and preventive care [26]. However, there is currently very little research on men’s involvement in and support for the promotion of HPV vaccination among women. A great deal of previous research has examined the acceptance and promotion of HPV vaccination in girls and young adult women [27–29]. Few studies have explored whether sexually active young men provide the necessary support to promote HPV vaccination among women. A qualitative study on social support for HPV vaccination among young women found that they typically discuss the HPV vaccine with parents, peers, and healthcare providers, but rarely with male partners [30]. It also revealed that sexual/romantic partners were more likely to provide emotional support if they had knowledge of HPV or HPV vaccine, familial experiences with HPV vaccine, or a personal or family history of HPV infection. However, it remains unclear how young Chinese adult men engage in and support women’s HPV vaccination, as well as the factors that influence their supportive behaviors and intentions. Adolescents and young adults assume multiple roles within social networks [31], including peer, family and romantic connections. When young men have a positive attitude toward HPV vaccination and actively share relevant information about vaccine administration, they can promote health education through their social networks [32, 33]. Meanwhile, their engagement with and support for HPV vaccination can directly influence the women around them, encouraging more women to receive the HPV vaccine [34]. Therefore, this study aimed to explore young Chinese adult men’s behaviors and willingness to support HPV vaccination in women. We also examined potential factors influencing supportive behaviors and willingness, with a focus on sociodemographic characteristics, sexual experience and history of HPV, knowledge about HPV and HPV vaccine, attitudes toward women’s HPV vaccination benefits, and information seeking for male HPV vaccination. Additionally, we elaborated on the potential role of men in promoting HPV vaccination. Methods Study design and setting Data for this study were obtained from a cross-sectional survey of the willingness and behaviors of male Chinese university students to support female HPV vaccination. The survey was conducted between December 2020 and January 2021 in Zhejiang, an eastern coastal province of China with 109 institutions of higher education and over 1.2 million college and graduate students, which ranks fourth in gross domestic product (GDP) among Chinese provinces. Eight universities from five regions in Zhejiang Province were sampled for this study using the multistage cluster sampling method, which considered the geographical location, economic development level, and size and type of universities. The sample size was estimated using the standard formula for a cross-sectional study: Assuming P as 0.5 for maximum population variance and a 95% confidence interval with Zα/2 = 1.96, the margin of relative error was set at δ = 0.05 (0.1*P), resulting in an estimated sample size of n = 385. To account for potential non-response rates and invalid questionnaires, the sample size was increased by 10%, leading to a minimum required sample size of 424 participants. Data collection A self-reported questionnaire was completed by the participants via an online survey platform Sojump. Researchers made phone calls to administrators from each university to obtain their cooperation and approval before the study commenced. Prior to the survey day at each university, the dormitory distribution on the main campus was gathered and dorms were selected based on their majors and grades. At each university, five investigators were recruited and trained by a professional researcher to collect data. Male students from a range of disciplines in selected dorms were invited to participate in the survey. The investigators explained the purpose of the survey and provided a printed quick-response code for the electronic questionnaire and detailed instructions for completing the study. Before filling out the questionnaire, respondents received information about the nature, scope, and purpose of the survey on the first page of the online questionnaire. They were assured that their responses would remain anonymous and confidential and that the data would be used strictly for scientific purposes. Participants were also informed that they could withdraw from the survey at any time. The survey began only after participants confirmed their understanding of this information and agreed to participate. No monetary compensation or gifts were offered for participation. The content and face validity of the questionnaire was confirmed by a panel that included four experts in public health, health education and promotion, and clinical medicine, five doctoral candidates with ample experience in quantitative research methodology, and sixteen college/university students, prior to piloting. To ensure reliability and validity, the questionnaire was pilot tested among 234 participants who were not included in the final sample. The Zhejiang University School of Public Health Research Ethics Committee granted ethical clearance for this study (ZGL202006-08). Measures Sociodemographic variables Sociodemographic variables included age, ethnicity, major, educational level, paternal and maternal educational levels, monthly household income (RMB), place of residence, sexual experience (defined as reporting having had sexual intercourse), relationship status (by inquiring whether men had a female partner), history of HPV infection, and family history of cervical cancer. HPV and HPV vaccine knowledge HPV and HPV vaccine knowledge was assessed using a series of 17 adapted questions [35–37]. The questions centered on basic knowledge regarding HPV infection (transmission route, susceptible population, and clinical features, etc.) and HPV vaccination (applicable population, vaccine efficacy, and vaccination process, etc.), with the following response options: “Yes,” “No,” and “Don’t know.” The overall knowledge score, ranging from 0 to 17, was computed by summing the correct answers and categorized as high level (score > 12) or low level (score ≤ 12) based on the median score. Cronbach’s alpha was 0.89, suggesting good internal consistency reliability. Attitudes toward women’s HPV vaccination benefits Attitudes toward the benefits of women’s HPV vaccination were assessed using a four-item scale adapted from the validated Carolina HPV Immunization Attitudes and Beliefs Scale (CHIAS) [38] and modified to suit the study objectives. We evaluated the effect of HPV vaccination on women’s health and its protective effects against HPV infections, genital warts, cervical cancer, and other related conditions. All items were rated on a five-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree). An average score was calculated, with higher values indicating greater endorsement of women’s HPV vaccination benefits. The scale demonstrated good internal reliability (Cronbach’s alpha = 0.97), construct validity, and convergent validity, with an average variance extracted (AVE) of 0.91 (> 0.5) and a composite reliability (CR) of 0.97 (> 0.7). Information-seeking for male HPV vaccination Information seeking was assessed by asking participants one simple question: “Have you ever actively sought information on male HPV vaccination?”, with the response options “Yes” or “No.” Behaviors and willingness to support HPV vaccination Behaviors and willingness to support HPV vaccination were each measured using two self-reported questions. These questions were developed based on pilot interviews with college and university students and findings from existing literature [30]. To ensure construct and face validity, four experts in public health, health education and promotion, and clinical medicine assessed these questions. Behaviors supporting HPV vaccination were assessed with the following two questions: (1) “Have you ever acquired and shared information about HPV vaccination with female partners, relatives, and friends?” and (2) “Have you ever recommended HPV vaccination to female partners, relatives, or friends?” Response options for each question were “Yes” or “No”. Participants who answered “No” to the first question were then asked about their willingness to acquire and share information about HPV vaccination with female partners, relatives, and friends in the future. Those who answered “No” to the second question were asked about their willingness to recommend HPV vaccination in the future. Willingness to support HPV vaccination was measured using a five-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree), with responses dichotomized into “Yes” (strongly agree and agree) and “No” (neutral, disagree, and strongly disagree) for data analysis. Statistical analyses Descriptive analyses included numbers and frequencies for categorical variables and medians, ranges, means, and standard deviations for continuous variables. Multivariable logistic regression analyses adjusted for all covariates were used to identify factors associated with behaviors and willingness to support HPV vaccination. Education level was excluded from the regression analyses to reduce collinearity with age. Statistical significance was set at p < 0.05. All analyses were performed using SPSS version 24.0 (SPSS Inc., Chicago, IL, USA). Results A total of 1014 respondents completed the online survey, with an average age of 20.90 ± 2.34 years. Sample characteristics are provided in Table 1. The majority of participants were undergraduates (71.7%) or postgraduates and higher students (25.7%). Students in medical departments comprised 276/1014 (27.2%) and non-medical students comprised 738/1014 (72.8%) of the survey participants. Slightly over half (53.2%) of the participants came from urban areas, and approximately 64% reported a monthly household income of between 5000 and 20,000 RMB ($725–2899). Additionally, 409 (40.3%) respondents had “low levels” of HPV and HPV vaccine knowledge, and 605 (59.7%) had “high levels” of knowledge. 23% of the participants reported having had sexual intercourse, and 36.8% reported having a female partner. A family history of cervical cancer was reported in 2.5% of men and 1.6% of participants had a history of HPV infection. Table 1Participants’ characteristics (n = 1014)CharacteristicN (%) aAge (years), Mean (SD)20.90 (2.34)Ethnicity Ethnic minorities41 (4.0) Han nationality937 (96.0)Education level Junior college student26 (2.6) Undergraduate727 (71.7) Postgraduate and above261 (25.7)Major Non-medicine738 (72.8) Medicine276 (27.2)Paternal education level Primary school and below117 (11.5) Junior high school339 (33.4) High school/technical secondary school278 (27.4) Junior college/university and above280 (27.6)Maternal education level Primary school and below211 (20.8) Junior high school351 (34.6) High school/technical secondary school244 (24.1) Junior college/university and above208 (20.5)Monthly household income (RMB) ≤¥ 5,000 ($725)178 (17.6) ¥ 5,001–10,000 ($725–1449)341 (33.6) ¥ 10,001–20,000 ($1450–2899)309 (30.5) >¥ 20,000 ($2899)186 (18.3)Place of residence Urban539 (53.2) Rural475 (46.8)HPV and HPV knowledge b Low level605 (59.7) high level409 (40.3)Sexual experience No678 (66.9) Yes233 (23.0) Refuse to answer103 (10.2)Currently have a female partner No641 (63.2) Yes373 (36.8)History of being diagnosed with HPV infection No/Not sure998 (98.4) Yes16 (1.6)Family history of cervical cancer No/Not sure989 (97.5) Yes25 (2.5)Information-seeking for male HPV vaccination No683 (67.4) Yes331 (32.6)Average score on attitudes toward women’s HPV vaccination benefits scale c Median4.14 Mean4.00 Std dev0.69 Minimum1 Maximum5a Data are noted as N (%) unless otherwise statedb An overall HPV and HPV vaccine knowledge score, ranging from 0 to 17, was computed and categorized as high level (score > 12) or low level (score ≤ 12) based on the median scorec Average score on the four-item HPV vaccination benefit scale was calculated, ranging from one to five, with higher values indicating greater endorsement Participants’ characteristics (n = 1014) a Data are noted as N (%) unless otherwise stated b An overall HPV and HPV vaccine knowledge score, ranging from 0 to 17, was computed and categorized as high level (score > 12) or low level (score ≤ 12) based on the median score c Average score on the four-item HPV vaccination benefit scale was calculated, ranging from one to five, with higher values indicating greater endorsement When asked about seeking information on male HPV vaccination, 331 (32.6%) participants had sought information on male HPV vaccination (Table 1). Of the 1014 respondents, 491 (48.4%) reported having acquired and shared information about HPV vaccination with their female partners, relatives, and friends, and 419 (41.3%) had recommended HPV vaccination to their female partners, relatives, and friends (Table 2). Of the 523 participants who had not acquired and shared information about HPV vaccination with women before the survey, 417 (79.7%) expressed a willingness to acquire and share more information about HPV vaccination in the future. Of the 595 participants who had never recommended HPV vaccination before the survey, 483 (81.2%) expressed willingness to recommend HPV vaccination in the future. Table 2Men’s willingness and behaviors to support HPV vaccinationVariablesN (%)Acquired and shared information about HPV vaccination with female partners, relatives, and friends(N = 1014) No523 (51.6) Yes491 (48.4)Recommended HPV vaccination to female partners, relatives, and friends(N = 1014). No595 (58.7) Yes419 (41.3)Willingness to acquire and share more information about HPV vaccination with female partners, relatives, and friends in the future a(N = 523) Strongly disagree4 (0.8) Disagree9 (1.7) Neutral93 (17.8) Agree273 (52.2) Strongly agree144 (27.5)Willingness to recommend HPV vaccination to female partners, relatives, and friends in the future a(N = 595) Strongly disagree4 (0.7) Disagree11 (1.8) Neutral97 (16.3) Agree320 (53.8) Strongly agree163 (27.4)a Willingness to support HPV vaccination was dichotomized as yes (strongly agree and agree) and no (neutral, disagree, and strongly disagree) for analyses Men’s willingness and behaviors to support HPV vaccination a Willingness to support HPV vaccination was dichotomized as yes (strongly agree and agree) and no (neutral, disagree, and strongly disagree) for analyses Table 3 shows all variables statistically associated with young men’s support behaviors for HPV vaccination. After adjusting for potentially confounding factors, older age, high levels of HPV and HPV vaccine knowledge, having had sexual intercourse, and currently having a female partner were associated with HPV vaccination information-acquiring and sharing and recommendation behaviors. Young men with a family history of cervical cancer were more likely to recommend HPV vaccination to their female partners, relatives, and friends (OR = 5.74, 95% CI 1.73–19.08). Similarly, those with positive attitudes toward the benefits of women’s HPV vaccination were more likely to recommend HPV vaccination (OR = 1.29, 95% CI 1.03–1.60). Young men who had ever actively sought information on male HPV vaccination were 7.55 times (95% CI 5.38–10.59) more likely to acquire and share information about HPV vaccination with female partners, relatives, and friends, and 4.12 times (95% CI 3.01–5.64) more likely to recommend HPV vaccination. Table 3Factors associated with support behaviors of HPV vaccination (n = 1014) aVariablesAcquired and shared information about HPV vaccination with female partners, relatives, and friendsRecommended HPV vaccination to female partners, relatives, and friendsOR (95% CI) p OR (95% CI) p Age (mean, SD)1.13 (1.06–1.21) < 0.001 1.13 (1.06–1.21) < 0.001 Ethnicity Ethnic minorities Ref.Ref. Han nationality0.98 (0.47–2.07)0.9671.34 (0.64–2.81)0.432Major Non-medicineRef. Medicine0.91 (0.64–1.28)0.5700.97 (0.7–1.35)0.855Paternal education level Primary school and belowRef. Junior high school1.67 (0.99–2.83)0.0561.29 (0.77–2.16)0.333 High school/technical secondary school1.52 (0.85–2.70)0.1580.89 (0.5–1.58)0.688 Junior college/university and above1.62 (0.85–3.06)0.1401.17 (0.62–2.19)0.625Maternal education level Primary school and belowRef. Junior high school1.43 (0.93–2.20)0.1051.33 (0.86–2.03)0.196 High school/technical secondary school1.61 (0.96–2.71)0.0731.53 (0.91–2.55)0.107 Junior college/university and above1.08 (0.58–2.00)0.8101.00 (0.54–1.84)0.991Monthly household income (RMB) ≤¥ 5,000 ($725)Ref. ¥ 5,001–10,000 ($725–1449)0.86 (0.56–1.34)0.5030.81 (0.52–1.24)0.329 ¥ 10,001–20,000 ($1450–2899)0.93 (0.59–1.47)0.7580.85 (0.54–1.33)0.472 >¥ 20,000 ($2899)0.92 (0.55–1.55)0.7510.83 (0.5–1.38)0.47Place of residence UrbanRef. Rural0.89 (0.63–1.26)0.5120.79 (0.56–1.11)0.172Knowledge level LowRef. high1.88 (1.38–2.57) < 0.001 2.06 (1.52–2.79) < 0.001 Sexual experience NoRef. Yes1.61 (1.09–2.38) 0.016 1.50 (1.03–2.18) 0.037 Refuse to answer1.01 (0.63–1.64)0.9590.76 (0.47–1.25)0.284Currently have a female partner NoRef. Yes2.13 (1.55–2.93) < 0.001 2.13 (1.56–2.91) < 0.001 History of being diagnosed with HPV infection No/Not sureRef. Yes1.80 (0.38–8.52)0.4591.55 (0.38–6.27)0.538Family history of cervical cancer No/Not sureRef. Yes1.81 (0.59–5.50)0.2995.74 (1.73–19.08) 0.004 Information-seeking for male HPV vaccination NoRef. Yes7.55 (5.38–10.59) < 0.001 4.12 (3.01–5.64) < 0.001 Attitudes toward women’s HPV vaccination benefits1.11 (0.89–1.38)0.3401.29 (1.03–1.60) 0.024 Boldface indicates statistical significanceCI = confidence interval; OR = odds ratio; Ref = Reference category in logistic regression analysisa Multivariable logistic regression analyses were adjusted for all covariates, with education level excluded to reduce collinearity with age Factors associated with support behaviors of HPV vaccination (n = 1014) a Boldface indicates statistical significance CI = confidence interval; OR = odds ratio; Ref = Reference category in logistic regression analysis a Multivariable logistic regression analyses were adjusted for all covariates, with education level excluded to reduce collinearity with age Among those who had never acquired and shared information about HPV vaccination before the survey, positive attitudes toward women’s HPV vaccination benefits were associated with greater self-reported willingness to acquire and share more information about HPV vaccination with their female partners, relatives, and friends (OR = 18.45, 95% CI 10.28–33.11). Yong men who had a high level of HPV and HPV vaccine knowledge (OR = 2.11, 95% CI 1.03–4.32) were more likely to express willingness to acquire and share more information about HPV vaccination with women in the future. However, male students whose mothers had a higher education, especially high school/technical secondary school (OR = 0.27, 95% CI 0.09–0.75) or junior college/university and above (OR = 0.25, 95% CI 0.07–0.90) compared to those whose mothers had primary school education and below, were less likely to express willingness to acquire and share more information about HPV vaccination with their female partners, relatives, and friends in the future. Details of the multivariable logistic regression models are presented in Table 4. Table 4Factors associated with men’s willingness to support women’s HPV vaccination aVariablesWillingness to acquire and share more information about HPV vaccination with female partners, relatives, and friends in the future (n = 523)Willingness to recommend HPV vaccination to female partners, relatives, and friends in the future(n = 595)OR (95%CI) p OR (95%CI) p Age (mean, SD)0.98 (0.86–1.13)0.8201.11 (0.96–1.27)0.169Ethnicity Ethnic minoritiesRef.Ref. Han nationality2.00 (0.50–7.98)0.3252.92 (0.75–11.35)0.121Major Non-medicineRef.Ref. Medicine0.90 (0.45–1.79)0.7530.85 (0.44–1.65)0.631Paternal education level Primary school and belowRef.Ref. Junior high school1.53 (0.59–3.96)0.3841.32 (0.50–3.46)0.579 High school/technical secondary school1.47 (0.50–4.30)0.4791.49 (0.52–4.28)0.455 Junior college/university and above1.67 (0.46–6.03)0.4371.29 (0.38–4.46)0.685Maternal education level Primary school and belowRef.Ref. Junior high school0.51 (0.22–1.19)0.1210.51 (0.22–1.19)0.117 High school/technical secondary school0.27 (0.09–0.75) 0.012 0.29 (0.11–0.79) 0.015 Junior college/university and above0.25 (0.07–0.90) 0.033 0.48 (0.14–1.68)0.253Monthly household income (RMB) ≤¥ 5,000 ($725)Ref.Ref. ¥ 5,001–10,000 ($725–1449)0.93 (0.41–2.14)0.8680.72 (0.31–1.64)0.429 ¥ 10,001–20,000 ($1450–2899)1.34 (0.55–3.26)0.5261.18 (0.49–2.83)0.709 >¥ 20,000 ($2899)0.46 (0.17–1.26)0.1320.46 (0.17–1.19)0.110Place of residence UrbanRef.Ref. Rural0.82 (0.41–1.64)0.5781.19 (0.62–2.31)0.604Knowledge level LowRef.Ref. high2.11 (1.03–4.32) 0.042 1.31 (0.66–2.64)0.442Sexual experience NoRef.Ref. Yes1.47 (0.6–3.61)0.4060.68 (0.28–1.68)0.405 Refuse to answer2.19 (0.81–5.88)0.1210.51 (0.21–1.22)0.129Currently have a female partner NoRef.Ref. Yes0.88 (0.45–1.74)0.7191.71 (0.85–3.42)0.133History of being diagnosed with HPV infection No/Not sureRef.Ref. Yes1.01 (0.99–1.02)0.9981.01 (0.99–1.02)0.999Family history of cervical cancer No/Not sureRef.Ref. Yes0.24 (0.01–5.70)0.3740.84 (0.01–80.81)0.941Information-seeking for male HPV vaccination NoRef.Ref. Yes2.15 (0.63–7.38)0.2241.83 (0.80–4.23)0.155Attitudes toward women’s HPV vaccination benefits18.45 (10.28–33.11) < 0.001 23.99 (13.15–43.76) < 0.001 Boldface indicates statistical significanceCI = confidence interval; OR = odds ratio; Ref = Reference category in logistic regression analysisa Multivariable logistic regression analyses were adjusted for all covariates, with education level excluded to reduce collinearity with age Factors associated with men’s willingness to support women’s HPV vaccination a Boldface indicates statistical significance CI = confidence interval; OR = odds ratio; Ref = Reference category in logistic regression analysis a Multivariable logistic regression analyses were adjusted for all covariates, with education level excluded to reduce collinearity with age Additionally, among those who had never recommended HPV vaccination to women before the survey, young men with positive attitudes toward women’s HPV vaccination benefits were 23.99 times (OR = 23.99, 95% CI 13.15–43.76) more likely to recommend HPV vaccination to their female partners, relatives, and friends in the future. Male students whose mother had a higher education, especially high school/technical secondary school (OR = 0.29, 95% CI 0.11–0.79) compared to those whose mothers had primary school education and below, were less likely to express willingness to recommend HPV vaccination to their female partners, relatives, and friends in the future (Table 4). Discussion To the best of our knowledge, this is the first study to examine behaviors of sexually active young Chinese men aged 16–26 years in supporting HPV vaccination and to analyze factors that influence supportive behaviors. We found that less than half of young men reported having supportive behaviors toward HPV vaccination in women, and the majority of participants without supportive behaviors reported their willingness to take a more active role in promoting HPV vaccination among women in the future. Factors influencing young men to support HPV vaccination were older age, high levels of HPV and HPV vaccine knowledge, having had sexual intercourse, currently having a female partner, having a family history of cervical cancer, positive attitudes toward women’s HPV vaccination benefits, and information-seeking for male HPV vaccination. Additionally, significant facilitators of men’s supportive willingness were high levels of HPV and HPV vaccine knowledge and positive attitudes toward women’s HPV vaccination benefits. Since the promotion of HPV vaccination in mainland China, health policies have reinforced public health initiatives focused on it [39]. Extensive media coverage and digital communication channels such as social media and online forums have rapidly spread HPV vaccination information to the public [40]. College-aged youth are active on social media [41], highly concerned about public issues [42], and rely on it as their important source for health information [43], which may enhance their awareness of HPV vaccination. A previous study conducted in Beijing, China, in 2018 found that over 70% of college students were aware of HPV vaccination, with 60% of male students being aware of it [44]. Our results showed that only 48.4% of young men had acquired and shared information about HPV vaccination with their female partners, relatives, and friends, and 41.3% had recommended women get vaccinated against HPV, indicating a relatively low level of awareness and support among males for female HPV vaccination. Further advocacy is necessary to encourage men’s active involvement in promoting HPV vaccination for women. Fortunately, although the occurrence rate of supportive behaviors was not high, approximately 80% of young men in our study expressed a strong willingness to recommend HPV vaccination to their female partners, relatives, and friends in the future. This result is higher than those of previous studies on the willingness of university students and fathers of primary school children to support their spouses or partners [45, 46]. In this study, 331 of 1014 young men reported actively seeking information on male HPV vaccinations. Interestingly, these men were more likely to acquire and share information about HPV vaccination with their female partners, relatives, and friends and recommend HPV vaccination. A possible explanation for this might be that the active pursuit of information about HPV vaccination in men contributes to an increase in men’s awareness and acceptance of HPV vaccination. This deepens their understanding of how the HPV vaccine protects the health of men and women. Consequently, men are more motivated to acquire and share information with women closest to them and recommend HPV vaccination. This suggests that men who pay greater attention to their health are more likely to support women’s preventive health behaviors, including promoting HPV vaccination. This supports previous findings that health attitudes and behaviors in intimate relationships can mutually promote and influence each other [47]. To some extent, these findings indicate that making informed decisions to prevent HPV infections and related STDs requires effective communication and information sharing in intimate relationships, especially between partners. It is crucial that men actively engage in communication regarding sexual health to effectively prevent diseases that may impact women’s health [48]. When men proactively communicate with women about sexual health issues, it not only alleviates the stigma experienced by women [49] but also increases the likelihood of men supporting their female partners and family members in accessing preventive healthcare services [50]. We found that young men with positive attitudes toward women’s HPV vaccination benefits were more likely to recommend HPV vaccination to women. Additionally, they expressed greater willingness to acquire and share more information about HPV vaccination and recommend it to their female partners, relatives, and friends in the future. This indicates that perceiving benefits not only promotes individual health behaviors [51, 52] but also motivates them to participate in health decision-making for people important to them. Thus, we can infer that when men are aware of the benefits of HPV vaccination for women’s health, their willingness to promote HPV vaccination is greatly enhanced. Health education and information regarding HPV vaccination should be targeted at men to empower them to take more responsibility for women’s health. Our findings revealed that several sociodemographic and health and risk factor variables were associated with behaviors and willingness to support HPV vaccination among young men. We found that older age, high levels of HPV and HPV vaccine knowledge, sexual experience, having a female partner, and a family history of cervical cancer were associated with behaviors related to acquiring and sharing information about HPV vaccination or making vaccination recommendations. These findings are consistent with previous studies that have reported that being in a relationship or having sexual experiences can motivate men to actively seek relevant health information and share it with their partners for mutual benefit [53]. Moreover, individuals with a family history of related diseases have been found to be more proactive in engaging in preventive behaviors [54]. Limitations We are aware of several limitations in this study that warrant consideration. First, causal inferences could not be determined from this cross-sectional study. Second, social desirability and recall biases could have affected the reliability of our findings from self-report questionnaires. Third, despite our efforts to include participants from different colleges and universities and diverse educational levels, it is important to acknowledge that the majority of our respondents were highly educated. This limits the generalizability of our findings. Furthermore, our study may not have sufficiently considered the potential differences between heterosexual men and those who identify as gay or bisexual owing to the sensitive nature of sexual orientations. We attempted to minimize this by asking the respondents whether they had girlfriends. To validate these findings, future studies should be conducted with more diverse and inclusive populations, encompassing a wider range of individuals from different backgrounds. Practice implications Promoting HPV vaccination for the elimination of cervical cancer carries implications that reach beyond women’s health. This study suggests that men could play a more active role in promoting HPV vaccination among women. First, it is crucial to raise awareness among men about the benefits of HPV vaccination on women’s health, which will greatly encourage men to provide adequate support in the decision-making process regarding HPV vaccination for women who are important to them. Second, encouraging men to actively pursue information about HPV vaccination can increase their likelihood of supporting the vaccination of women. Specifically, we suggest that future health education programs should not exclusively focus on eligible women but should also encompass men. Health information should emphasize the impact of HPV infection on the health of men and women to foster a sense of shared involvement in the prevention of STDs among both sexes. Meanwhile, strengthening communication within intimate relationships is imperative for involving men in cervical cancer prevention initiatives. Although HPV vaccination is not yet available to men in mainland China, increasing their awareness of the risks associated with HPV infection and its impact on their health is essential. This is of great significance in promoting men’s self-care and concern for the health of their female partners and family members. Conclusions In summary, this study highlights the need to increase the involvement of young adult men in supporting and promoting female HPV vaccinations in China. We found that young men who actively sought information on male HPV vaccination were more likely to support female HPV vaccination or expressed a willingness to support vaccination in the future. Targeted health education regarding HPV vaccination should include men by emphasizing the benefits of HPV vaccination to encourage men’s active engagement in the decision-making process regarding HPV vaccination for their female partners and family members. Acknowledgements The author owes a debt of gratitude to all the participants for their participation and kind cooperation during this study. Abbreviations Human papillomavirus Sexually transmitted diseases Gross domestic product Author contributions WW conceptualized and designed the study; WW collected and analyzed the data; WW drafted and reviewed the manuscript, and provided final approval. Funding This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Data availability The datasets generated and analyzed during the current study are not publicly available due to reasons of privacy and ethical considerations. The instruments are available from the corresponding author upon reasonable request. Declarations Ethics approval and consent to participate The Zhejiang University School of Public Health Research Ethics Committee granted ethical clearance for this study (ZGL202006-08). Each participant was fully briefed on the objectives, anonymity, confidentiality, and voluntary nature of the study, and provided informed consent. Consent for publication Not applicable. Competing interests The author declares no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement The datasets generated and analyzed during the current study are not publicly available due to reasons of privacy and ethical considerations. The instruments are available from the corresponding author upon reasonable request.